Objective: To describe clinical, electrophysiologic, neuroimaging, and musc
le biopsy features in a hereditary spastic paraplegia (HSP) kindred linked
to a new HSP locus on chromosome 8q. Background: HSP is a genetically diver
se group of disorders characterized by insidiously progressive spastic weak
ness in the legs. We recently analyzed a Caucasian kindred with autosomal d
ominant HSP and identified tight linkage to a novel HSP locus on chromosome
8q23-24. Methods: Clinical analysis, nerve conduction studies, electromyog
raphy, somatosensory evoked potentials, MRI of brain and spinal cord, and m
uscle biopsy for mitochondrial analysis were performed in members of the fi
rst HSP kindred linked to chromosome 8q. Results: Fifteen individuals showe
d insidiously progressive spastic paraparesis beginning between ages 22 and
60 years (average, 37.2 years). Spinal cord MRI in 1 moderately affected s
ubject showed significant atrophy of the thoracic spinal cord as determined
by cross-sectional area measurements. Somatosensory evoked potential recor
ding, electromyography, nerve conduction studies, and muscle biopsy, includ
ing histochemical and biochemical analysis of mitochondrial function, were
normal. Conclusions: The phenotype in this family is that of typical, but s
evere, uncomplicated HSP. Other than apparently increased severity, there w
ere no clinical features that distinguished this family from autosomal domi
nant HSP linked to loci on chromosomes 2p, 14q, and 15q. This clinical simi
larity between different genetic types of autosomal dominant HSP raises the
possibility that genes responsible for these clinically indistinguishable
disorders may participate in a common biochemical cascade. Normal results o
f muscle histochemical and biochemical analysis suggest that mitochondrial
disturbance, a feature of chromosome 16-linked autosomal recessive HSP due
to paraplegin gene mutations, is not a feature of chromosome 8q-linked auto
somal dominant HSP and may not be a common factor of HSP in general.